Home > Publishers > Mellalta Meets LLP
  • Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Publisher
Filter

Mellalta Meets LLP Report List

mell
Mellalta Meets LLP is a research-based consultancy with a global footprint. They have worked with firms around the world to help optimize business strategy and transform their business decisions. Additionally, they help Pharma & Biotech companies stay on top of the competition, and provide customized intelligence reports.

Filter
Title Search
1 - 25 of 33 Products Sort by Display
Major Depressive Disorder (MDD) | Primary Research (KOL's Insight) | Competitive Intelligence | Market Analytics & Forecast 2032
Published by
Mellalta Meets LLP
Product code
1067325
Published
March 25, 2022
Content info
267 Pages
Price
USD 6500
Sample available
Rett Syndrome (RTT) | Primary Research (KOL's Insight) | Competitive Intelligence | Market Analytics & Forecast 2032
Published by
Mellalta Meets LLP
Product code
1067324
Published
February 28, 2022
Content info
165 Pages
Price
USD 6500
Sample available
Anti-Cluster of differentiation 19 (CD19) Antibody - Pipeline Analytics 2022
Published by
Mellalta Meets LLP
Product code
1067323
Published
January 31, 2022
Content info
71 Pages
Price
USD 2500
Sample available
Anti-Cluster of differentiation 38 (CD38) Antibody - Pipeline Analytics 2022
Published by
Mellalta Meets LLP
Product code
1067322
Published
January 31, 2022
Content info
86 Pages
Price
USD 2500
Sample available
Pediatric Crohn's Disease (pCD)| Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast - 2030
Published by
Mellalta Meets LLP
Product code
1043374
Published
November 30, 2021
Content info
182 Pages
Price
USD 6500
Sample available
Metastatic Renal Cell Carcinoma (mRCC) | Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast - 2030
Published by
Mellalta Meets LLP
Product code
1043373
Published
November 30, 2021
Content info
293 Pages
Price
USD 6500
Sample available
Neuromyelitis Optica Spectrum Disorder (NMOSD) | Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast - 2030
Published by
Mellalta Meets LLP
Product code
1043372
Published
November 30, 2021
Content info
178 Pages
Price
USD 6500
Sample available
Cluster of Differentiation 47 (CD47) Inhibitors - Pipeline Analytics 2021
Published by
Mellalta Meets LLP
Product code
1043371
Published
October 31, 2021
Content info
151 Pages
Price
USD 2500
Sample available
Gamma Delta T Cell Therapy - Pipeline Analytics 2021
Published by
Mellalta Meets LLP
Product code
1043370
Published
October 31, 2021
Content info
125 Pages
Price
USD 2500
Sample available
Anti Neutralizing Antibodies (NAbs) Gene Therapies - Pipeline Analytics 2021
Published by
Mellalta Meets LLP
Product code
1043369
Published
October 31, 2021
Content info
110 Pages
Price
USD 2500
Sample available
Lumbar Radiculopathy (Sciatica)| Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast - 2030
Published by
Mellalta Meets LLP
Product code
1031005
Published
October 5, 2021
Content info
181 Pages
Price
USD 6500
Sample available
Complex Regional Pain Syndrome (CRPS)| Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast - 2030
Published by
Mellalta Meets LLP
Product code
1031004
Published
October 5, 2021
Content info
147 Pages
Price
USD 6500
Sample available
Signaling Regulatory Protein (SIRP) alpha Inhibitors - Pipeline Analytics 2021
Published by
Mellalta Meets LLP
Product code
1043368
Published
September 30, 2021
Content info
101 Pages
Price
USD 2500
Sample available
Signal Transducer and Activator of Transcription 3 (STAT3) Inhibitors - Pipeline Analytics 2021
Published by
Mellalta Meets LLP
Product code
1043367
Published
September 30, 2021
Content info
140 Pages
Price
USD 2500
Sample available
Mitochondrial Epilepsy (MIT-E) | Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast - 2030
Published by
Mellalta Meets LLP
Product code
1030730
Published
August 31, 2021
Content info
151 Pages
Price
USD 6500
Sample available
Wolfram Syndrome (WS) | Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast - 2030
Published by
Mellalta Meets LLP
Product code
1030733
Published
July 31, 2021
Content info
127 Pages
Price
USD 6500
Sample available
Corticobasal Syndrome (CBS) | Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast-2030
Published by
Mellalta Meets LLP
Product code
1030732
Published
July 31, 2021
Content info
105 Pages
Price
USD 6500
Sample available
Progressive Supranuclear Palsy (PSP) | Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast - 2030
Published by
Mellalta Meets LLP
Product code
1030731
Published
July 31, 2021
Content info
144 Pages
Price
USD 6500
Sample available
Peripheral T-cell lymphoma (PTCL)| Primary Research (KOL's Insight) | Competitive Intelligence | Market Analytics & Forecast 2030
Published by
Mellalta Meets LLP
Product code
1015906
Published
June 22, 2021
Content info
190 Pages
Price
USD 6500
Sample available
Adult Acute Lymphoblastic Leukemia (aALL) | Primary Research (KOL's Insight) | Competitive Intelligence | Market Analytics & Forecast 2030
Published by
Mellalta Meets LLP
Product code
1015905
Published
June 22, 2021
Content info
172 Pages
Price
USD 6500
Sample available
Chimeric Antigen Receptor (CAR-T) Cell Therapy - Market Opportunity, Pipeline & Competitive Intelligence 2020
Published by
Mellalta Meets LLP
Product code
1015904
Published
June 22, 2021
Content info
1,083 Pages
Price
USD 4000
Sample available
Wet Age-related Macular Degeneration (wAMD)| Primary Research (KOL's Insight) | Competitive Intelligence | Market Analytics & Forecast 2030
Published by
Mellalta Meets LLP
Product code
997048
Published
March 16, 2021
Content info
166 Pages
Price
USD 6500
Sample available
TIGIT Inhibitors - Market Opportunity, Pipeline & Competitive Intelligence 2020
Published by
Mellalta Meets LLP
Product code
997051
Published
February 28, 2021
Content info
Price
USD 3950
Sample available
Obstructive Sleep Apnea (OSA) | Primary Research (KOL's Insight) | Competitive Intelligence | Market Analytics & Forecast 2030
Published by
Mellalta Meets LLP
Product code
997049
Published
February 28, 2021
Content info
152 Pages
Price
USD 6500
Sample available
Central Precocious Puberty | Primary Research (KOL's Insight) | Competitive Intelligence | Market Analytics & Forecast 2030
Published by
Mellalta Meets LLP
Product code
997046
Published
February 28, 2021
Content info
100 Pages
Price
USD 6500
Sample available
Compare
item is currently selected
Compare products
Delete all